Cardiovascular Monitoring and Diagnostic Devices Market by Product Type (ECG systems, Holter Monitors, Event Monitors, Implantable loop recorders, and ECG Management Systems) ¬- Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

December 2016 | 110 pages | ID: C48FB262E05EN
Zion Market Research

Abstracts

The report covers forecast and analysis for the cardiovascular monitoring and diagnostic devices market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the cardiovascular monitoring and diagnostic devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cardiovascular monitoring and diagnostic devices market on a global level.

This report offers comprehensive coverage on global cardiovascular monitoring and diagnostic devices market along with, market trends, drivers, and restraints of cardiovascular monitoring and diagnostic devices market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the cardiovascular monitoring and diagnostic devices market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the cardiovascular monitoring and diagnostic devices market by segmenting the market based on product type, and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The product type market covered under this study includes ECG systems, holter monitors, event monitors, implantable loop recorders, ECG management systems. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America and the Middle East Africa.

Key operating players for cardiovascular monitoring and diagnostic devices market are Boston Scientific Corporation, Welch Allyn, Inc., FUKUDA DENSHI Co., Ltd., GE Healthcare, Sorin Group, Johnson Johnson, Medtronic, Inc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare, St. Jude Medical, Inc and Welch Allyn, Inc.

This report segments the cardiovascular monitoring and diagnostic devices market as follows:

Global Cardiovascular Monitoring and Diagnostic Devices Market: Product Type Analysis

ECG systems.
Resting ECG systems
Stress ECG systems
Holter Monitors
Event Monitors
Implantable loop recorders
ECG management systems

Global Cardiovascular Monitoring and Diagnostic Devices Market: Regional analysis
North America
U.S.
Europe
U.K.
Germany
France
Asia
India
China
Japan
Latin America
Brazil
Middle East and Africa

Contents

CHAPTER 1. INTRODUCTION

1.1. Report Description And Scope
1.2. Research Scope
1.3. Research Methodology
  1.3.1. Market Research Process
  1.3.2. Market Research Methodology

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Global cardiovascular monitoring and diagnostic devices market, 2015 - 2021 (USD Billion)
2.2. Global cardiovascular monitoring and diagnostic devices market: Snapshot

CHAPTER 3. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET MARKET DYNAMICS

3.1. Introduction
3.2. Value Chain Analysis
3.3. Market Drivers
  3.3.1. Global cardiovascular monitoring and diagnostic devices market Drivers: Impact Analysis
  3.3.2. Increasing prevalence of cardiovascular diseases
  3.3.3. Rising investment for medical device manufacturing
3.4. Global cardiovascular monitoring and diagnostic devices market Restraints: Impact Analysis
  3.4.1. Uncertainty in reimbursement
  3.4.2. High cost of treatment
3.5. Opportunities
  3.5.1. Untapped market like developing countries
  3.5.2. Increasing prevalence of lifestyle diseases
3.6. Porters Five Forces Analysis
  3.6.1. Bargaining Power Of Suppliers
  3.6.2. Bargaining Power Of Buyers
  3.6.3. Threat From New Entrants
  3.6.4. Threat From New Substitutes
  3.6.5. Degree Of Competition
3.7. Market Attractiveness Analysis
  3.7.1. Market Attractiveness Analysis, by Product Type Segment
  3.7.2. Market Attractiveness Analysis, by Regional Segment

CHAPTER 4. GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET COMPETITIVE LANDSCAPE

4.1. Company Market Share, 2014 (Subject To Data Availability)
4.2. Strategic Development
  4.2.1. Acquisitions Mergers
  4.2.2. New Source Launch
  4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
  4.2.4. Research And Development, Product And Regional Expansion
4.3. Product Portfolio
4.4. Patent Analysis (2011-2016)
  4.4.1. Patent Trend
  4.4.2. Patent Share By Company
  4.4.3. By Region

CHAPTER 5. GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET PRODUCT TYPE ANALYSIS

5.1. Global cardiovascular monitoring and diagnostic devices market: Product type Segment Overview
  5.1.1. Global cardiovascular monitoring and diagnostic devices market Revenue Share, By Product type Segment, 2015 And 2021
5.2. ECG systems
  5.2.1. Global cardiovascular monitoring and diagnostic devices market for ECG systems, 2015 - 2021 (USD Billion)
5.3. Holter Monitors
  5.3.1. Global cardiovascular monitoring and diagnostic devices market for Holter Monitors, 2015 - 2021 (USD Billion)
5.4. Event Monitors
  5.4.1. Global cardiovascular monitoring and diagnostic devices market for Event Monitors, 2015 - 2021 (USD Billion)
5.5. Implantable loop recorders
  5.5.1. Global cardiovascular monitoring and diagnostic devices market for Implantable loop recorders, 2015 - 2021 (USD Billion)
5.6. ECG management systems
  5.6.1. Global cardiovascular monitoring and diagnostic devices market for ECG management systems, 2015 - 2021 (USD billion)

CHAPTER 6. GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES MARKET REGIONAL SEGMENT ANALYSIS

6.1. Global cardiovascular monitoring and diagnostic devices market: Regional Overview
  6.1.1. Global cardiovascular monitoring and diagnostic devices market Revenue Share, By Region, 2014 And 2020
6.2. North America
  6.2.1. North America cardiovascular monitoring and diagnostic devices market Revenue, by product type, 2015 - 2021 , (USD Billion)
  6.2.2. U.S.
    6.2.2.1. U.S. cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
6.3. Europe
  6.3.1. Europe cardiovascular monitoring and diagnostic devices market Revenue, by product type, 2015 - 2021 , (USD Billion)
  6.3.2. U.K.
    6.3.2.1. U.K. cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
  6.3.3. Germany
    6.3.3.1. Germany cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
  6.3.4. France
    6.3.4.1. France cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
6.4. Asia Pacific
  6.4.1. Asia Pacific cardiovascular monitoring and diagnostic devices market Revenue, by product type classification, 2015 - 2021 , (USD Billion)
  6.4.2. India
    6.4.2.1. India cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
  6.4.3. China
    6.4.3.1. China cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
  6.4.4. Japan
    6.4.4.1. Japan cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
6.5. Latin America
  6.5.1. Latin America cardiovascular monitoring and diagnostic devices market Revenue, by product type, 2015 - 2021 , (USD Billion)
  6.5.2. Brazil
    6.5.2.1. Brazil cardiovascular monitoring and diagnostic devices market Revenue, by Product type 2015 - 2021 , (USD Billion)
6.6. Middle East and Africa
  6.6.1. Middle East and Africa cardiovascular monitoring and diagnostic devices market Revenue, by product type, 2015 - 2021 , (USD Billion)

CHAPTER 7. COMPANY PROFILE

7.1. Boston Scientific Corporation
  7.1.1. Overview
  7.1.2. Financials
  7.1.3. Product Portfolio
  7.1.4. Business Strategy
  7.1.5. Recent Developments
7.2. Welch Allyn, Inc.,
  7.2.1. Overview
  7.2.2. Financials
  7.2.3. Product Portfolio
  7.2.4. Business Strategy
  7.2.5. Recent Developments
7.3. FUKUDA DENSHI Co., Ltd.,
  7.3.1. Overview
  7.3.2. Financials
  7.3.3. Product Portfolio
  7.3.4. Business Strategy
  7.3.5. Recent Developments
7.4. GE Healthcare
  7.4.1. Overview
  7.4.2. Financials
  7.4.3. Product Portfolio
  7.4.4. Business Strategy
  7.4.5. Recent Developments
7.5. Sorin Group
  7.5.1. Financials
  7.5.2. Product Portfolio
  7.5.3. Business Strategy
  7.5.4. Recent Developments
7.6. Johnson Johnson
  7.6.1. Financials
  7.6.2. Product Portfolio
  7.6.3. Business Strategy
  7.6.4. Recent Developments
7.7. Medtronic Inc.
  7.7.1. Overview
  7.7.2. Financials
  7.7.3. Product Portfolio
  7.7.4. Business Strategy
  7.7.5. Recent Developments
7.8. Nihon Kohden Corporation
  7.8.1. Overview
  7.8.2. Financials
  7.8.3. Product Portfolio
  7.8.4. Business Strategy
  7.8.5. Recent Developments
7.9. Philips Healthcare
  7.9.1. Overview
  7.9.2. Financials
  7.9.3. Product Portfolio
  7.9.4. Business Strategy
  7.9.5. Recent Developments
7.10. Siemens Healthcare
  7.10.1. Overview
  7.10.2. Financials
  7.10.3. Product Portfolio
  7.10.4. Business Strategy
  7.10.5. Recent Developments
7.11. Spacelabs Healthcare
  7.11.1. Overview
  7.11.2. Financials
  7.11.3. Product Portfolio
  7.11.4. Business Strategy
  7.11.5. Recent Developments
7.12. St. Jude Medical, Inc.
  7.12.1. Overview
  7.12.2. Financials
  7.12.3. Product Portfolio
  7.12.4. Business Strategy
  7.12.5. Recent Developments